UTIs Therapeutics Pipeline Comprises More Drug Candidates Being Developed as Combination Therapies: P&S Market Research NEW YORK, March 19, 2018 (GLOBE NEWSWIRE) -- UTIs therapeutics currently exhibits a proliferating pipeline with 40 drug candidates, according to P&S Market Research. Urinary tract infection...